WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Boom in travel to 'ice city' Harbin spurs sales of cranberry productsXi Sends Congratulatory Letter to CrossRestructuring high on SOE agendaBeverage grading system launched in ShanghaiBoom in travel to 'ice city' Harbin spurs sales of cranberry productsState energy firms turn to renewables abroadChina launches new Earth observation satelliteLuxury brands embrace the Year of the DragonYearender: Silicon Valley keeps trends as Artificial Intelligence goes mainstream in 2017Xi Meets Cambodian Prime Minister